TRMK(TRMK)
TRMK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $847M | $887M |
| Low | $838M | $867M |
| High | $853M | $898M |
| EBITDA Avg | $199M | $208M |
| Low | $197M | $203M |
| High | $200M | $211M |
| EBIT Avg | $153M | $160M |
| Low | $152M | $157M |
| High | $154M | $162M |
| Net Income Avg | $236M | $248M |
| Low | $233M | $246M |
| High | $240M | $250M |
| EPS Avg | $3.90 | $4.09 |
| Low | $3.85 | $4.07 |
| High | $3.96 | $4.13 |
| Analysts (Rev / EPS) | 3 / 5 | 3 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $210M | $215M | $217M | $215M | $220M | $225M | $227M |
| Low | $209M | $213M | $216M | $214M | $219M | $224M | $226M |
| High | $212M | $216M | $218M | $216M | $222M | $226M | $229M |
| EBITDA Avg | $49M | $50M | $51M | $50M | $52M | $53M | $53M |
| Low | $49M | $50M | $51M | $50M | $51M | $53M | $53M |
| High | $50M | $51M | $51M | $51M | $52M | $53M | $54M |
| EBIT Avg | $38M | $39M | $39M | $39M | $40M | $41M | $41M |
| Low | $38M | $38M | $39M | $39M | $40M | $40M | $41M |
| High | $38M | $39M | $39M | $39M | $40M | $41M | $41M |
| Net Income Avg | $57M | $59M | $59M | $56M | $60M | $62M | $63M |
| Low | $55M | $58M | $58M | $56M | $59M | $62M | $63M |
| High | $58M | $60M | $59M | $57M | $60M | $63M | $64M |
| EPS Avg | $0.96 | $1.00 | $1.00 | $0.95 | $1.01 | $1.05 | $1.07 |
| Low | $0.94 | $0.99 | $0.99 | $0.95 | $1.00 | $1.05 | $1.06 |
| High | $0.98 | $1.01 | $1.00 | $0.96 | $1.02 | $1.06 | $1.08 |
| Analysts (Rev / EPS) | 3 / 5 | 3 / 4 | 2 / 2 | 1 / 2 | 2 / 1 | 2 / 1 | 1 / 2 |